Gary W. Miller, Ph.D., serves as vice dean for research strategy and innovation and professor of environmental health sciences at Columbia University’s Mailman School of Public Health. He also has appointments in the Department of Molecular Pharmacology and Therapeutics and the Department of Neurology in the Vagelos College of Physicians and Surgeons. He is an international leader on the exposome, the environmental analogue to the genome.
Dr. Miller founded the first exposome center in the United States and wrote the first book on the topic. He has helped develop high-resolution mass spectrometry methods to provide an omic-scale analysis of the human exposome. He serves as co-director of Columbia University’s Precision Medicine Resource, which supports integration of environmental measures into clinical and translational research projects.
Dr. Miller completed his Ph.D. in pharmacology and toxicology at the University of Georgia and postdoctoral training in molecular neuroscience at Emory University and Duke University. From 1998 to 2002, he was a faculty member in the Division of Pharmacology and Toxicology at the University of Texas at Austin. In 2002, Dr. Miller moved to Emory University, where he served as professor in the Gangarosa Department of Environmental Health in the Rollins School of Public Health and the Departments of Pharmacology and Neurology in the School of Medicine. He served as associate dean for research in the Rollins School of Public Health from 2009 to 2018. He moved to Columbia University in 2018.
Dr. Miller’s laboratory research focuses on environmental drivers of neurodegeneration, including Parkinson’s disease and Alzheimer’s disease. His research utilizes Caenorhabditis elegans, transgenic mouse models, and human studies using a variety of techniques. Dr. Miller served as editor-in-chief of Toxicological Sciences, the official journal of the Society of Toxicology, from 2013 to 2019 and is the founding editor of the new journal Exposome, published by Oxford University Press. He is on the Scientific Advisory Board of NIH’s Human Health Exposure Analysis Resource (HHEAR) and the Scientific Advisory Board for the Human Biomonitoring for the European Union (HBM4EU) project.
